Clinical Trial Update: Intralipid for Recurrent Miscarriage [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for intralipid in recurrent miscarriage has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Habitual Abortion
• Spontaneous Abortion

Drugs mentioned

• Intralipid (intravenous lipid emulsion)

Snippet

Sponsor: Woman's Health University Hospital, Egypt | Conditions: Abortion, Spontaneous, Abortion, Habitual | Phase 4 | Status: COMPLETED